| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Barclays analyst Christine Cho maintains Stem (NYSE:STEM) with a Equal-Weight and raises the price target from $13 to $18.
UBS analyst Jon Windham maintains Stem (NYSE:STEM) with a Neutral and raises the price target from $16 to $18.
Stem (NYSE:STEM) narrows FY2025 sales outlook from $125.000 million-$175.000 million to $135.000 million-$160.000 million vs $1...
Stem (NYSE:STEM) reported quarterly losses of $(2.84) per share which missed the analyst consensus estimate of $(2.54) by 11.68...